# AI-Powered Pharma Biostats Platform - Complete Guide

## Overview

NuPhorm has been transformed into a fully AI-powered pharmaceutical biostatistics platform with advanced features for regulatory compliance, intelligent analysis suggestions, multimodal support, and comprehensive PDF report generation.

## Core Features

### 1. Auto-Baseline Analysis
Automatically computes comprehensive baseline analysis on file upload:
- **Descriptive Statistics**: Mean, median, std dev, quartiles, min, max, range
- **Data Quality Assessment**: Missing values, data quality score (0-100)
- **Pharma Metrics**: Bioavailability, bioequivalence ratios, efficacy rates
- **Data Characteristics Detection**: Identifies survival data, dose data, efficacy data, safety data, paired data
- **Suggested Analyses**: Generates context-aware analysis recommendations

### 2. Smart NLP Engine
Intelligent natural language processing for analysis suggestions:
- **Intent Detection**: Identifies analysis types from user queries
- **Confidence Scoring**: Ranks detected intents by confidence
- **Context-Aware Suggestions**: Adapts suggestions based on data characteristics
- **Follow-Up Questions**: Generates intelligent follow-up prompts
- **Data Insights**: Provides actionable insights about data quality and characteristics

**Supported Analysis Types:**
- Kaplan-Meier Survival Analysis
- Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling
- Bioavailability/Bioequivalence (BA/BE) Analysis
- Dose-Response Modeling
- Efficacy Analysis
- Safety Assessment
- Correlation Analysis
- Group Comparisons

### 3. Comprehensive PDF Report Generation
Generates professional pharma reports with sections:
- **Introduction**: Data summary and analysis objectives
- **Methods**: Statistical methods and regulatory framework
- **Results**: Key findings and statistical results
- **Discussion**: AI-generated pharma insights and regulatory assessment

**Report Features:**
- FDA/EMA compliance assessment
- Regulatory recommendations
- Risk assessment
- Confidence intervals and effect sizes
- Benefit-risk analysis

### 4. Multimodal Image Analysis
Analyzes pharmaceutical images:
- **Gel Blots**: Band detection, intensity quantification, densitometry
- **Chromatograms**: Peak detection, area calculation, purity assessment
- **Spectra**: Feature identification, signal-to-noise ratio
- **Microscopy**: Cell counting, staining intensity, fluorescence quantification

**Image Analysis Output:**
- Detected features (bands, peaks, spots)
- Quantification results
- Quality assessment
- Suggested analyses

### 5. Pharma Metrics Calculation
Comprehensive pharmaceutical calculations:
- **Bioequivalence**: AUC/Cmax ratios, 90% CI, FDA criteria compliance
- **Efficacy**: Effect sizes (Cohen's d), NNT, relative risk, odds ratio
- **Safety**: Adverse event rates, discontinuation rates, safety indices
- **PK Parameters**: Cmax, Tmax, AUC, half-life, clearance, Vd
- **PD Parameters**: Emax, EC50, slope, baseline effect

### 6. Backend Computation Engine
Optional Express.js backend for heavy computations:
- Python integration via child_process for advanced statistical modeling
- R integration via rserve-js for specialized pharma statistics
- Database storage for reports and analysis history
- Caching for frequently used calculations

## Sample Pharma Queries and Outputs

### Query 1: Bioequivalence Analysis
**User Query:** "Check bioequivalence of test vs reference formulation"

**System Response:**
```
Detected Intent: Bioavailability/Bioequivalence Analysis (Confidence: 0.92)
Suggested Analysis: Bioavailability/Bioequivalence Analysis - Compare formulations against FDA criteria
Explanation: Your data suggests a bioavailability/bioequivalence study. We'll calculate the ratio and confidence interval to assess FDA compliance.

Follow-up Suggestions:
- Want to perform a detailed bioequivalence assessment?
- Should we check EMA criteria in addition to FDA?
- Would you like to assess individual bioequivalence?

Data Insights:
- Data quality is good. Proceed with confidence.
- Both efficacy and safety data present. Benefit-risk analysis recommended.
```

**Generated Report Section (Discussion):**
```
Regulatory Perspective:
✓ The data supports bioequivalence per FDA criteria (90% CI within 80-125% for AUC and Cmax).
AUC ratio: 102.5% (90% CI: 95.2-109.8%) meets FDA acceptance range.
Cmax ratio: 98.3% (90% CI: 91.1-105.5%) meets FDA acceptance range.

Conclusions:
This analysis provides robust evidence supporting bioequivalence of the test formulation to the reference product, meeting all FDA regulatory requirements for generic drug approval.
```

### Query 2: Survival Analysis
**User Query:** "Analyze survival outcomes by treatment group"

**System Response:**
```
Detected Intent: Kaplan-Meier Survival Analysis (Confidence: 0.95)
Suggested Analysis: Kaplan-Meier Survival Analysis - Visualize survival curves and compare groups
Explanation: Your data appears to contain survival/time-to-event information. Kaplan-Meier analysis is ideal for visualizing survival curves and comparing treatment groups.

Follow-up Suggestions:
- Would you like to perform a log-rank test to compare survival curves?
- Should we stratify by treatment group or other covariates?
- Want to assess safety events alongside survival?

Data Insights:
✓ Survival/time-to-event data detected. Kaplan-Meier analysis is recommended.
📊 Both efficacy and safety data present. Benefit-risk analysis recommended.
```

### Query 3: Efficacy Assessment
**User Query:** "Calculate efficacy and effect size for treatment vs control"

**System Response:**
```
Detected Intent: Efficacy Analysis (Confidence: 0.88)
Suggested Analysis: Efficacy Analysis - Calculate responder rates and effect sizes
Explanation: Your query focuses on efficacy. We can calculate responder rates, effect sizes, and number needed to treat.

Results:
- Cohen's d (Effect Size): 0.75 (Medium effect)
- Number Needed to Treat (NNT): 4 patients
- Responder Rate: 60% in treatment vs 40% in control
- Relative Risk: 1.50x higher in treatment group

Key Finding:
The treatment demonstrates a clinically meaningful effect size with moderate efficacy. One additional positive outcome is achieved for every 4 patients treated.
```

### Query 4: Image Analysis
**User Query:** "Analyze gel blot image for band quantification"

**System Response:**
```
Image Type: Gel Blot
Quality Score: 87/100
Contrast Level: High
Noise Level: Low

Detected Bands:
- Band 1: Position Y=125, Intensity=220, Area=2500
- Band 2: Position Y=250, Intensity=195, Area=2100
- Band 3: Position Y=375, Intensity=180, Area=1900

Quantification:
- Total Intensity: 595
- Average Band Intensity: 198.3
- Density Distribution: [0, 0, 2, 1, 0, 0, 0, 0, 0, 0]

Suggested Analyses:
- Quantify band intensities for densitometry analysis
- Compare band patterns across samples
- Estimate molecular weights from band positions
```

## Database Schema

### pharma_reports
Stores comprehensive analysis reports with sections, tables, figures, and regulatory assessment.

### analysis_history
Tracks all analyses performed with queries, results, and execution metrics.

### pharma_data_files
Manages uploaded data files with metadata, characteristics, and baseline analysis.

### image_analysis_results
Stores image analysis results including detected features and quantification.

### pharma_metrics_cache
Caches computed metrics for performance optimization.

### report_templates
Stores reusable report templates for different analysis types.

### user_pharma_preferences
Stores user preferences for analysis types, confidence levels, and report formats.

## API Endpoints (tRPC Procedures)

### Data Analysis
- `pharma.autoAnalyzeData`: Run baseline analysis on uploaded data
- `pharma.processQuery`: Process user query with NLP
- `pharma.calculateBioequivalence`: Compute BA/BE metrics
- `pharma.calculateEfficacy`: Compute efficacy metrics

### Report Generation
- `pharma.generateReport`: Generate comprehensive pharma report
- `pharma.saveReport`: Save report to database
- `pharma.getSavedReports`: Retrieve saved reports
- `pharma.deleteReport`: Delete report
- `pharma.exportReportPDF`: Export report as PDF

### Image Analysis
- `pharma.analyzeImage`: Analyze pharmaceutical images

### History & Management
- `pharma.getAnalysisHistory`: Retrieve analysis history
- `pharma.getSavedReports`: Get saved reports with filtering

## Frontend Components

### Enhanced Biostatistics Page
- **File Upload Zone**: Drag-and-drop with auto-baseline analysis
- **Smart Chat Interface**: NLP-powered suggestions and follow-ups
- **Baseline Analysis Panel**: Data quality, characteristics, suggested analyses
- **Report Generator**: One-click report generation with customization
- **Image Upload**: Multimodal support for gel blots and chromatograms
- **Results Display**: Charts, tables, and statistical summaries
- **Report Preview**: In-app report viewing before export

### Report Viewer
- **PDF Export**: Professional PDF with all sections
- **Interactive Tables**: Sortable, filterable results tables
- **Chart Visualization**: Publication-quality charts with customization
- **Regulatory Assessment**: FDA/EMA compliance status

## Integration Guide

### Step 1: File Upload
1. User uploads CSV/XLSX file
2. System automatically runs baseline analysis
3. Data characteristics detected
4. Suggested analyses displayed

### Step 2: Query Processing
1. User types natural language query
2. NLP engine detects analysis intent
3. System generates suggestions
4. User selects preferred analysis

### Step 3: Analysis Execution
1. Appropriate statistical methods applied
2. Pharma metrics calculated
3. Results computed with confidence intervals
4. Insights generated

### Step 4: Report Generation
1. User clicks "Generate Report"
2. System compiles all results
3. AI generates discussion section
4. Report formatted with sections
5. PDF exported or saved to database

## Regulatory Compliance

### FDA Criteria
- **Bioequivalence**: 90% CI for AUC and Cmax within 80-125%
- **Efficacy**: Effect size ≥ 0.2, statistical significance p < 0.05
- **Safety**: Serious AE rate < 5%, discontinuation rate < 10%

### EMA Criteria
- Similar to FDA with additional requirements
- Stricter confidence interval requirements in some cases
- Additional documentation requirements

## Performance Optimization

### Caching
- Frequently used calculations cached in database
- 24-hour cache expiration
- Manual cache invalidation available

### Parallel Processing
- Multiple analyses can run simultaneously
- Image analysis parallelized across bands/peaks
- Report generation optimized for large datasets

### Database Indexing
- User ID indexed for fast retrieval
- Analysis type indexed for filtering
- Timestamp indexed for sorting

## Sample Data Files

### Gene Expression Data (sample_gene_expression.csv)
```
gene_id,control_value,treated_value
GENE001,100,150
GENE002,200,150
GENE003,50,200
...
```

### Clinical Trial Data (sample_trial_data.csv)
```
subject_id,treatment,baseline,week4,week8,adverse_event
001,treatment,100,85,75,no
002,control,105,102,100,no
003,treatment,98,70,60,yes
...
```

### PK/PD Data (sample_pk_pd_data.csv)
```
time_hours,concentration_ng_ml,effect_percent
0,0,0
1,150,25
2,280,45
4,320,65
8,180,40
...
```

## Best Practices

1. **Data Quality**: Ensure data is clean with minimal missing values
2. **Sample Size**: Aim for n ≥ 30 for robust statistical power
3. **Documentation**: Include data dictionary and study protocol
4. **Regulatory Context**: Specify intended regulatory pathway
5. **Validation**: Validate results against known standards
6. **Interpretation**: Consider clinical significance alongside statistical significance

## Troubleshooting

### Low Data Quality Score
- Check for missing values
- Remove outliers if justified
- Ensure consistent units and formats

### No Analysis Suggestions
- Verify data characteristics are detected correctly
- Check column names for standard pharma terms
- Ensure sufficient numeric data

### Report Generation Fails
- Verify all required fields are populated
- Check for special characters in titles
- Ensure sufficient memory for large datasets

## Future Enhancements

1. **Machine Learning**: Predictive modeling for trial outcomes
2. **Real-Time Collaboration**: Multi-user report editing
3. **Advanced Visualization**: Interactive 3D plots and heatmaps
4. **Regulatory Integration**: Direct FDA/EMA submission formatting
5. **AI-Powered Insights**: Deeper pharmacological interpretation
6. **Mobile App**: Native iOS/Android applications
7. **API Access**: RESTful API for external integrations

## Support and Documentation

For detailed API documentation, see `server/routers/pharmaRouter.ts`.
For statistical functions, see `server/statisticsCalculator.ts`.
For pharma metrics, see `server/ai/pharmaMetrics.ts`.

---

**Version**: 1.0.0  
**Last Updated**: February 2026  
**Platform**: NuPhorm AI-Powered Pharma Biostats Platform
